FR2314731A1 - Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients - Google Patents

Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients

Info

Publication number
FR2314731A1
FR2314731A1 FR7618273A FR7618273A FR2314731A1 FR 2314731 A1 FR2314731 A1 FR 2314731A1 FR 7618273 A FR7618273 A FR 7618273A FR 7618273 A FR7618273 A FR 7618273A FR 2314731 A1 FR2314731 A1 FR 2314731A1
Authority
FR
France
Prior art keywords
azacycloalcan
substitutes
excipients
ones
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7618273A
Other languages
English (en)
French (fr)
Other versions
FR2314731B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nelson Research and Development Co
Original Assignee
Nelson Research and Development Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/588,247 external-priority patent/US3989816A/en
Priority claimed from US05/588,248 external-priority patent/US3989815A/en
Priority claimed from US05/588,235 external-priority patent/US3991203A/en
Application filed by Nelson Research and Development Co filed Critical Nelson Research and Development Co
Publication of FR2314731A1 publication Critical patent/FR2314731A1/fr
Application granted granted Critical
Publication of FR2314731B1 publication Critical patent/FR2314731B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A61F2005/415—Devices for promoting penis erection by inflatable means

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
FR7618273A 1975-06-19 1976-06-16 Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients Granted FR2314731A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58823475A 1975-06-19 1975-06-19
US05/588,247 US3989816A (en) 1975-06-19 1975-06-19 Vehicle composition containing 1-substituted azacycloheptan-2-ones
US05/588,248 US3989815A (en) 1975-06-19 1975-06-19 Novel N-bis-azacyclopentan-2-onyl alkanes
US05/588,235 US3991203A (en) 1975-06-19 1975-06-19 Vehicle composition containing 1-substituted azacyclopentan-2-ones

Publications (2)

Publication Number Publication Date
FR2314731A1 true FR2314731A1 (fr) 1977-01-14
FR2314731B1 FR2314731B1 (enExample) 1978-11-03

Family

ID=27504982

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7618273A Granted FR2314731A1 (fr) 1975-06-19 1976-06-16 Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients

Country Status (7)

Country Link
JP (1) JPS6037092B2 (enExample)
AU (1) AU504943B2 (enExample)
CA (1) CA1076028A (enExample)
DE (1) DE2627772A1 (enExample)
FR (1) FR2314731A1 (enExample)
GB (1) GB1553309A (enExample)
IE (1) IE43241B1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2537438A1 (fr) * 1982-12-09 1984-06-15 Oreal Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525199A (en) * 1981-05-04 1985-06-25 Nelson Research & Development Co. Method of improved pest control
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
JPS536327A (en) * 1976-07-08 1978-01-20 Mizusawa Industrial Chem Waterrresistant gypsum cureemolding structure
US4311481A (en) 1981-01-23 1982-01-19 Nelson Research & Development Company Method for improved dyeing
JPS5995212A (ja) * 1982-11-23 1984-06-01 Nitto Electric Ind Co Ltd 基剤組成物及び外用医薬組成物
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
JPH0627074B2 (ja) * 1984-07-25 1994-04-13 日東電工株式会社 医薬組成物
JPS61130207A (ja) * 1984-11-30 1986-06-18 Sunstar Inc 養毛剤
PT89837B (pt) * 1988-02-29 1994-01-31 Pfizer Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina
JPH0742213B2 (ja) * 1990-07-04 1995-05-10 花王株式会社 毛髪処理剤組成物
JPH0742214B2 (ja) * 1990-07-04 1995-05-10 花王株式会社 毛髪処理剤組成物
JPH0742215B2 (ja) * 1990-07-04 1995-05-10 花王株式会社 毛髪処理剤組成物
US6284754B1 (en) 1992-01-20 2001-09-04 Schwarz Pharma Ag Pharmaceutical compositions containing 1-oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes
KR100212961B1 (ko) * 1992-12-31 1999-08-02 조민호 경피투여시스템
DE4341572C1 (de) * 1993-12-07 1995-06-22 Univ Dresden Tech Zahnriemengetriebe
DE19641437A1 (de) * 1996-10-08 1998-04-09 Basf Ag 1,3-Bis-(N-lactamyl)propane und deren pharmazeutische und kosmetische Verwendung
BRPI0511504A (pt) 2004-05-26 2008-01-22 Eisai R&D Man Co Ltd composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides
ATE458729T1 (de) 2004-10-26 2010-03-15 Eisai R&D Man Co Ltd Amorphe form einer zimtsäureamidverbindung
JP4504210B2 (ja) * 2005-01-25 2010-07-14 花王株式会社 染毛剤組成物
AU2006316005A1 (en) * 2005-11-18 2007-05-24 Eisai R & D Management Co., Ltd. Process for production of cinnamamide derivative
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
US20080207900A1 (en) 2007-02-28 2008-08-28 Teiji Kimura Two cyclic oxomorphorin derivatives
US20100113348A1 (en) 2007-03-01 2010-05-06 Fumio Kamiyama Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
ES2529648T3 (es) 2007-08-31 2015-02-24 Eisai R&D Management Co., Ltd. Compuesto policíclico
JP2012020991A (ja) 2010-06-16 2012-02-02 Takasago Internatl Corp 経皮吸収促進剤、及びこれを含有する皮膚外用製剤
EP3395368A1 (en) 2014-10-30 2018-10-31 Asahi Kasei Kabushiki Kaisha Transdermal absorption enhancer and transdermal absorption enhancement aid

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1053736B (de) * 1956-03-02 1959-03-26 Konink Nl Gist & Spiritusfabri Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
DE1192208B (de) * 1960-05-13 1965-05-06 Basf Ag Verfahren zur Herstellung von Lactamen
US3268397A (en) * 1963-10-04 1966-08-23 Gen Aniline & Film Corp Method of controlling nematodes with nu-(branched-chained-alkyl) lactams
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
DE2252102A1 (de) * 1971-10-29 1973-05-03 Gaf Corp Phenol/lactam-komplexe
NL7310404A (enExample) * 1972-07-28 1974-01-30

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE859016C (de) * 1944-07-06 1952-12-11 Basf Ag Verfahren zur Herstellung von N-substituierten Lactamen

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1053736B (de) * 1956-03-02 1959-03-26 Konink Nl Gist & Spiritusfabri Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
DE1192208B (de) * 1960-05-13 1965-05-06 Basf Ag Verfahren zur Herstellung von Lactamen
US3268397A (en) * 1963-10-04 1966-08-23 Gen Aniline & Film Corp Method of controlling nematodes with nu-(branched-chained-alkyl) lactams
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
DE2252102A1 (de) * 1971-10-29 1973-05-03 Gaf Corp Phenol/lactam-komplexe
NL7310404A (enExample) * 1972-07-28 1974-01-30

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2537438A1 (fr) * 1982-12-09 1984-06-15 Oreal Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone

Also Published As

Publication number Publication date
JPS6037092B2 (ja) 1985-08-24
IE43241B1 (en) 1981-01-14
AU1506376A (en) 1977-12-22
CA1076028A (en) 1980-04-22
FR2314731B1 (enExample) 1978-11-03
AU504943B2 (en) 1979-11-01
JPS521035A (en) 1977-01-06
GB1553309A (en) 1979-09-26
DE2627772A1 (de) 1976-12-30
DE2627772C2 (enExample) 1991-04-25
IE43241L (en) 1976-12-19

Similar Documents

Publication Publication Date Title
BE843140A (fr) Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
BE849632A (fr) Composition pharmaceutique pour l'administration orale
BE842329A (fr) Nouveaux esters-17b d'oestradiol et compositions therapeutiques renfermant des esters-17b d'oestradiol
BE843865A (fr) Nouvelles formulations de medicaments a danger d'emploi abusif reduit
FR2273555A1 (fr) Agent d'administration intravasculaire
BE852444A (fr) Compositions pharmaceutiques anti-inflammatoires
BE837579A (fr) Compositions destinees a l'hygiene buccale
FR2341307A1 (fr) Pyrethrinoides a titre de medicaments et compositions pharmaceutiques les renfermant
PH12363A (en) Oral pharmaceutical compositions of nandrolone-17 esters with a non-steroidal lipoid
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
FR2280391A1 (fr) Composes heterocycliques et leur utilisation a titre d'agents parfumants et aromatisants
BE833394A (fr) Composition pharmaceutique destinee a faciliter l'accouchement
BE884896A (fr) Composition orale destinee a combattre le tartre dentaire et a ameliorer l'hygiene buccale
BE861888A (fr) Compositions contenant un derive de l'acide salicyclique et applications a titre de medicament
ZA773747B (en) Pharmaceutical compositions containing organic derivatives of montmorillonite
BE827595A (fr) Medicament a administration par voie orale produisant un effet inhibiteur de l'antiplasmine
IL52433A0 (en) A novel 2-phenylimino-imidazolidine derivative and salts thereof their preparation and pharmaceutical compositions containing them
FR2344291A1 (fr) Composition pour l'application topique d'un medicament
NZ195058A (en) 2b-acetoxymethyl-(5r)-2-methyl-penam-3-carboxylic acid 1, 1-dioxide and salts and esters thereof pharmaceutical compositions
BE864124A (fr) Compositions pharmaceutiques analgesiques et anti-inflammatoires
BE839187A (fr) Derives d'histidine, procedes pour leur preparation et compositions therapeutiques contenant ces composes
FR2505826B1 (fr) Derives d'isoprenylamine et compositions pharmaceutiques preparees avec ces derives
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
IL52547A0 (en) A novel n-pyrrolidylmethyl-benzamide derivative and its salts their preparation and pharmaceutical compositions containing them
FR2315923A1 (fr) Derives de l'isoxazole et medicament contenant ces substances